The Royal Pharmaceutical Society (RPS) Scotland has launched an online pharmacy best practice hub to showcase the best practices adopted by pharmacy teams in
Scotland.
The brand new pharmacy best practice hub, hosted on the RPS Scotland website, went live on Thursday (August 11).
RPS Scotland said: "Pharmacy teams across Scotland are undertaking fantastic work right now, in a variety of settings including community, hospital and general
practice pharmacy as well as specialist settings.
Many of these examples demonstrate the very best in pharmacy practice, which is supporting the profession to move further towards RPS Scotland's professional vision
for the future of pharmacy, Pharmacy 2030."
RPS wants to celebrate and share these examples with healthcare professionals, government, politicians, the public and potential pharmacy students to inspire people
into the profession. It also provides a fantastic opportunity for pharmacy teams to share their practice with each other across the country.
Pharmacy Business will be hosting their annual awards event in the pharmacy calendar with a glittering ceremony to celebrate the very best of community pharmacy.
The 23rd edition of the Pharmacy Business Awards will be on Wednesday 4 October 2023 in central London.
The awards attract the biggest names in pharmacy, with heads of pharmacy organisations, CEOs of leading manufacturers and wholesalers, health officials and
government ministers in attendance.
We look forward to bringing together the shining lights of community pharmacy, who show the nation the unique services they continue to provide.
REASONS TO ATTEND
Understand what the ambitions of the NHS and PSNC are for the future of community pharmacy
Understand why its important to develop a wider range of health services
Learn how others are achieving this and what the benefits can be
Learn what the benefits of embracing technological innovations are
Hear what others are doing and what the benefits are to their business
Network with and learn from your peers in community pharmacy
WHO SHOULD ATTEND?
Pharmacy owners
Pharmacy managers
Other pharmacy stakeholders
Exciting news! Pharmacy Business Awards 2023 are just around the corner!
The pharmacy inquiry will explore issues impacting different types of pharmacy, with a particular focus on community, primary care and hospital pharmacy
services.
It will also consider current challenges around funding, workforce and the digital infrastructure.
Planned developments within the profession will enable future pharmacists to be independent prescribers from day one of registration, giving them a greater role
within primary care teams.
Health and Social Care Committee Chair Steve Brine MP said: "It is clear that pharmacy has a central role to play in the future of the NHS. With a greater focus on
personalised and patient-centred healthcare, we will be asking what more must be done to make sure that the profession is in the best shape to meet demand.
"Better use of the pharmacy workforce would reduce pressures on general practice and hospitals. However, this will not happen without a planned workforce with the
funding, supervision and training to support it.
"At the end of the inquiry, the committee will be making recommendations to the government on what action needs to be taken to ensure the potential of pharmacy is
realised.
Jonathan Burton will receive the 2022 RPS Charter Award for his outstanding work for the Society and the wider profession in promoting the interests of pharmacy.
The award will be presented by the President at a future meeting of Fellows and Members to take place at the Society's Edinburgh office on 22nd March 2023.
Jonathan's main role is as a practising, patient-facing pharmacist within the community in NHS Forth Valley where he uses his advanced practice skills and independent
prescribing qualification to assess and treat acute ENT, dermatology, and respiratory conditions.
He was one of the first community pharmacist prescribers in Scotland and has always been at the forefront of innovation and service development.
Jonathan has demonstrated outstanding commitment and passion for the pharmacy profession throughout his career. He has excelled as a pharmacist in the Right Medicine
Pharmacy group, on local and national committees, in advocacy for the pharmacy profession and as a local and national leader who is highly regarded as an exceptional
role model for the profession.
Today I'm proud to share with you the statement we submitted to the UK Commission on Pharmacy Professional Leadership in which we set out what professional
leadership means to RPS.
I recognise we haven't always been clear in communicating our ideas to members and our external stakeholders. Through the Commission, and our own Independent
Review of member participation and communications, we are determined to remedy this.
We're committed to lead pharmacy in the best interest of patients and the professions. This means that sometimes we will need to take difficult decisions. We will
do the right thing for the long term, ultimately driving what's best for patient care.
There are some key changes we believe are necessary to fulfil the profession's ambitions.
To achieve a more unified approach to pharmacy leadership, we believe both pharmacists and pharmacy technicians should be represented by RPS within professional
faculties that capitalise on the strengths of each discipline whilst retaining distinct professional voices.
Many of our members work with pharmacy technicians every day and know just how essential they are to their role and to patient care. We feel the same at RPS and it
makes perfect sense to evolve into an organisation where both professions can advance their scope of practice, working in alignment as part of the wider
multi-professional team.
We will develop and implement post-registration curricula and credentialing for all pharmacists and pharmacy technicians working with patients and the public. To
do this we will require formal delegation of authority by the GPhC.
Politicians, researchers and pharmacy leaders called on the government to make community pharmacy a fundamental part of clinical services at an event at the
House of Commons on Wednesday (13).
At the launch of a research publication carried out by the University of Bath in conjunction with Sigma Pharmaceuticals, community pharmacy was described as
an "essential pillar of health care provision" in the UK.
The aim of this research was to provide evidence to support a strategy for the future developments of community pharmacy to ensure the sector continues to meet
the needs of the public in the NHS.
Researchers analysed 25 health and community pharmacy related policies published by the department of health, the NHS, the pharmacy profession, and spoke to
stakeholders from a wide range of backgrounds, including patients, pharmacists, NHS commissioners and GPS.
Professional leadership bodies from around the world discussed workforce shortages in community pharmacy and other challenges affecting the sector at a global
meeting held in Paris last month.
Delegated from Denmark, Australia, Ireland, New Zealand, Portugal, Spain, US and the UK updated the conference on how the profession was progressing in practice,
technology and workforce development in their respective countries.
The UK was represented at World Pharmacy Council meeting by National Pharmacy Association chair Andrew Lane and chief executive at the Pharmaceutical Services
Negotiating Committee Janet Morrison.
Lane said: "It's very useful to be part of a global network of pharmacy bodies who are all going through similar challenges as we are in the UK. Sharing intelligence
on other pharmacy systems around the world helps us to prepare the right strategy for engaging with the NHS at home.
"Hearing some of the strides in services and digital technology in the profession gives us hope for the future of the sector. It's clear however that key challenges
such as workforce shortages are starting to have an effect in other parts of the world too."
At last Friday's Clinical Congress Conference, the NHSE Chief Pharmaceutical Officer for England at NHS England, David Webb, announced the upcoming launch
of the Pharmacy Stakeholder Forum- an initiative led by NHS England aimed to improve pharmacy professional leadership and foster collaboration within the sector.
Webb highlighted the forum's significance as a platform for driving transformative change in pharmacy leadership.
"The aim is to deliver collaboration to develop a stronger and more united voice for pharmacy professionals," Webb emphasised.
Highlighting the need to drive transformative change in pharmacy leadership, he underscored that "the overarching goal is to address key challenges facing the
pharmacy profession and chart a course for future development and innovation."
Scheduled to commence in June, the Pharmacy Stakeholder Forum will provide a space for diverse organisations and networks with a vested interest in pharmacy
professional leadership to converge.
The future of community pharmacies is in danger. With some 639 local pharmacies closing in England since 2016, action is clearly needed to ensure their
longevity and maintain their rightful place on the high street.
With increasing pressure on the NHS, which is suffering from healthcare backlogs and long waiting lists following the harsh impact of the pandemic, pharmacies
have an opportunity to create a more substantial contribution within the healthcare industry.
To ensure that pharmacies are able to embrace this opportunity, they need to be equipped with the necessary tools to enable them to meet the needs of an increasingly
digital population.
One way of doing this is to support pharmacies online, by providing them with a means to connect to patients via mobile, tablet or desktop. In turn, the UK population
needs to be more aware of the services that can be provided by a pharmacist - many of which would save them from visiting a GP.
The Royal Pharmaceutical Society (RPS) has confirmed it will respond to UK Commission's 'call for evidence' on pharmacy professional leadership.
The commission wants to ensure the professions are well equipped, with a voice to help shape the future, and enabled to develop through sharing and learning from
best practice.
The UK Commission on Pharmacy Professional Leadership has been set up by the chief pharmaceutical officers of England, Scotland, Wales and Northern Ireland. It will
produce recommendations for the future of pharmacy professional leadership in the UK.
The commission is co-chaired by Nigel Clarke, former chair of the General Pharmaceutical Council, and Professor Dame Jane Dacre, professor of medical education at
University College London's Medical School.
The commission will be hosting a webinar and has urged the associations and individuals to take part in 'call for evidence' which has been launched to inform and
develop its work.
A webinar in England will take place on Wednesday 7 September 6:30 - 8 pm. In Scotland it will be organised on Tuesday 6 September 7-8:30 pm and in Wales it will be
hosted on Thursday 8 September 7-8:30 pm.
The Royal Pharmaceutical Society (RPS) has appointed Laura Wilson as Director for Scotland commencing 23rd January 2023.
Laura, is currently Policy and Practice Lead for RPS in Scotland. She is accountable for bringing national RPS policy to life for members in Scotland, while
contributing to the GB wide professional leadership agenda.
She will work closely with the Scottish Pharmacy Board, senior NHS officials and other key stakeholders across the breadth of the pharmacy profession and beyond
to ensure pharmacy is on the forefront of healthcare in Scotland.
She joins the existing team of RPS Country Directors, which includes Elen Jones, Director for Wales and James Davies, Director for England and will report directly
to the Chief Executive.
Laura Wilson said: "I am delighted to be appointed Director for Scotland having worked as part of the RPS Scotland team as the policy and practice lead. It will
be an honour to continue the fantastic work started by former Director Clare Morrison to bring Pharmacy 2030, our vision for pharmacy in Scotland in the future,
to life and supporting pharmacy teams to deliver person centred care.
The Pharmacists' Defence Association (PDA) has urged its member - employed pharmacists and locum pharmacists to share their view on UK Commission on Pharmacy
Professional Leadership report.
The four government Chief Pharmacists have published their commission's proposal for how pharmacy leadership may develop in the UK.
The association 'strongly' believes that just as it was the members of the profession that established their previous pharmacist professional leadership bodies, so
it is for pharmacists to determine if they agree with these proposals and to decide what arrangements they want in future.
"As an organisation that has exclusively in its membership the employed and locum pharmacists in the UK, the PDA wants to ensure that it can reflect the views of
frontline pharmacists in any future discussions and decisions that could impact upon their careers.
Pharmacists are encouraged to read the report, to consider its content and then ensure they respond to the forthcoming communication from the PDA."
The commission report says that existing leadership bodies have "relatively low levels of membership" but does not provide details. It has also stated that it has
received submissions to its consultation from many pharmacy organisations.
The Royal Pharmaceutical Society has stated that the UK Commission on Pharmacy Professional Leadership lacks the essential transparency, efficiency, and
diligence needed for success, urging a shift in its approach.
The Commission's operational approach hinders its ability to meet the expectations of both the profession and the public, while prioritising government interests
over their needs and preferences, RPS Chief Executive Paul Bennett (R) and President Claire Anderson have jointly said.
In a blog post on September 7, the RPS leaders asserted that the Commission lacks transparency and is progressing slowly in implementing proposals that were published
seven months ago. "Most pharmacy leaders are growing frustrated and increasingly impatient with the Commission's perceived lack of "meaningful progress" in enhancing
leadership within the field," the pair noted.
In June 2022, the four UK Chief Pharmaceutical Officers (CPhOs) formed an independent Commission with leadership expertise drawn from various domains, both within
and outside of pharmacy, to assess the future of professional leadership. The Pharmacy Minister Neil O'Brien recently revealed that the Commission's costs, funded
by the offices of the CPhOs, amounted to £87,745.
The Royal Pharmaceutical Society (RPS) has re-joined the International Pharmaceutical Federation (FIP) after reflecting its commitment to international
collaboration and the advancement of the pharmacy profession.
RPS President Professor Claire Anderson said: "Members told us they wanted to see us re-join FIP to further our commitment to international partnerships which
support education and advocacy to develop and progress the pharmacy profession.".
"We fully recognise the importance of international collaboration and the sharing of knowledge and best practice with our peers across the world.
"FIP are refocusing their membership offer and we're delighted to work with them on opportunities for professional development and increased visibility and
recognition for the pharmacy profession."
Paul Bennett, RPS CEO said: "Now that we have re-joined, our teams across RPS look forward to reinvigorating the close collaboration we have previously enjoyed
with our colleagues both within FIP itself, and across the breadth of FIP Member organisations to further our vision and mission".
In an open letter to pharmacy colleagues, the Royal Pharmaceutical Society (RPS) praised the work being done by them over this "extremely busy period."
Expressing gratitude towards pharmacists RPS said "Patients rely on you and we are so proud of the work you are doing."
It said the incredible work of pharmacists, in all settings, have ensured that patients have access to medicines and advice during the pandemic.
Calling pharmacists an integral part of the profession, RPS said they not only prescribe and advise the public, but also play a key role in teaching future pharmacists, developing new medicines, running and supporting clinical trials.
The Pharmacists' Defence Association (PDA) has submitted a 17-page contribution to the commission on the future of pharmacy professional leadership and
encourages pharmacists to engage in the overall discussion.
The association wants to ensure that the voice of its members is heard in the discussions about the future of professional leadership, which has been initiated by
the four government Chief Pharmaceutical Officers.
The PDA has published its first formal contribution to the commission, in its response it raised concern on the current exercise is being rushed and a call for the
review to be conducted in a more sensible timeframe, one which enables the engagement of the whole profession.
It has urged on being supportive of the creation of a Royal College of Pharmacists to take custodianship of the training and education for pharmacists and to set the
requisite standards, whilst still relying upon the profession's regulators to undertake the accreditation role.
Leading pharmacy bodies and associations are looking forward to working with 'reappointed' Secretary of State for Health and Social Care, Steve Barclay, on
'future roles' and 'funding' for the community pharmacy.
The Royal Pharmaceutical Society (RPS) England Country Board Chair, Thorrun Govind, hopes that the ministers will now be able to focus on addressing the key
challenges facing the health service and the country.
"This means not just getting through the winter, but planning for and investing in the future."
She added: "It will be crucial to use the skills of all our health professions to support the NHS recovery, reduce health inequalities, manage the growing cost
of long-term conditions, and deliver best value from medicines.
In a significant development, the British Medical Association's (BMA) consultants committee has voted to accept the government's offer on pay for senior
doctors in England, along with proposed reforms to the Review Body on Doctors' and Dentists' Remuneration (DDRB).
This decision follows a prolonged dispute between consultants and the government, which spanned over a year, involving unprecedented industrial actions.
Committee Chair Vishal Sharma described the agreement as "the end of the beginning" in consultants' endeavors to restore their pay levels to those of 2008.
Stressing the importance of the review body's independence in averting future pay disputes, Sharma emphasized the imperative role of utilizing this autonomy
effectively.
A staggering 83% of consultants participating in the three-week referendum voted in favor of accepting the offer, signaling a widespread endorsement of the
agreement within the profession.
The UK government will lay legislation today (13 December 2023) to allow the General Medical Council (GMC) to begin the process of regulating medical
associates to expand their roles in the NHS.
This will support plans to reduce pressure on doctors and GPs and improve access for patients, the Department of Health and Social Care (DHSC) said.
Physician associates (PAs) and anaesthesia associates (AAs) will have the same levels of regulatory oversight and accountability as doctors and other regulated
healthcare professionals once the regulations come into force, which is expected at the end of 2024.
The GMC will design and deliver detailed regulatory processes for registration, education, standards and fitness to practise for both professions.